Nuclear ETFs Renew Interest on AI Power Demand, But Cameco's Operational Hurdles Persist

What happened

A recent article highlights increasing interest in nuclear ETFs as AI-driven electricity demand and government support for nuclear capacity expansion create a favorable backdrop for the sector. For Cameco, this macro tailwind reinforces the long-term demand thesis for uranium, but the company's near-term challenges — including the temporary Cigar Lake shutdown, extended Key Lake maintenance, and compressed margins from replacement purchases — remain unaddressed. The DeepValue report assigns a WAIT rating with a current price of $95.80, noting that the stock trades at 90.4x P/E and 51x EV/EBITDA, with no valuation margin of safety. Execution risk is elevated: Cigar Lake must restart soon, Key Lake's Q3 outage must stay on schedule, and purchased-pound costs must not overrun realized prices to protect margins. While the nuclear renaissance narrative strengthens, Cameco's specific operational milestones will determine whether the stock can justify its premium multiple in the next 6–9 months.

Implication

The bull case for Cameco depends on flawless execution in the second half of 2026: Cigar Lake restart, Key Lake maintenance completion, and McArthur Zone 1 ramp-up. If those occur without margin erosion from replacement purchases, the stock could reach $118. However, any delays or guidance cuts could push fair value toward $76. The macro tailwind from AI and nuclear policy is already priced in, leaving limited upside. Thus, the prudent strategy is to wait for the next one or two quarterly updates to confirm operational progress before committing capital. The current price offers no margin of safety, and the risk of operational disappointment outweighs the potential reward.

Thesis delta

The nuclear sector's tailwind from AI power demand and government support is a positive backdrop, but it does not change the near-term operational risks that Cameco faces. The market's optimism about the nuclear renaissance is already fully reflected in the stock's premium valuation. The thesis shifts from 'buy the nuclear theme' to 'wait for operational proof points,' as the next 6–9 months will test whether Cameco can execute without margin compression.